glp-1 colorectal cancer mortality study november 2025 Association between receptor agonists as a class and risk: a meta-analysis of retrospective cohort studies | BMC Gastroenterology Colon cancer patients using GLP-1s

Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM , Ohman EM

Deloch et al., 2018a]

INJECTIONS Immediate Benefits: Sustained Weight Loss Improved Cardiovascular Outcomes Improved Blood Glucose Control Appetite Suppression

If not, we want to see how we can moderate our protocols so that the patient undergoing a total hip arthroplasty who is also taking a GLP-1 agonist can have the most ideal experience possible for their surgery.

We conducted a meta-analysis of GLP-1RAs versus control interventions in patients with KOA

One user found her dizziness only occurred when she took her injection after 7pm